Nano‐gold micelles loaded Dox and Elacridar for reversing drug resistance of breast cancer-Reference-Cited by-同舟云学术

Nano‐gold micelles loaded Dox and Elacridar for reversing drug resistance of breast cancer

Published:2022-11-07 Issue:2 Volume:17 Page:49-60
ISSN:1751-8741
Container-title:IET Nanobiotechnology
language:en
Short-container-title:IET Nanobiotechnology

Author:

Wen Liu‐Jing¹^ORCID,Wang Yue‐Sheng²,Zhang Jie¹

Affiliation:

1. Department of Pharmacy Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Tianjin China

2. Department of Dentistry Second Hospital Affiliated to Tianjin Medical University Tianjin China

Publisher

Institution of Engineering and Technology (IET)

Subject

Electrical and Electronic Engineering,Biotechnology,Electronic, Optical and Magnetic Materials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1049/nbt2.12102

Reference33 articles.

1. Graphene-based materials: A new tool to fight against breast cancer

2. Immunotherapy and targeted therapy combinations in metastatic breast cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Triterpene-Based bioactive drug delivery system for combined chemotherapy of liver cancer;European Journal of Pharmaceutics and Biopharmaceutics;2024-08

2. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles;Journal of Drug Targeting;2024-07-05

3. Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives;International Journal of Molecular Sciences;2024-05-27

4. Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity;Environmental Research;2023-12